Biotech | March 14, 2022
Clarivate deals report highlights emerging trends in biopharma deal-making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud
It will be the first and only global office for traditional medicine in the world
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Subscribe To Our Newsletter & Stay Updated
